icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
HCV Screening/treatment in UK Prisons Can be Cost-Effective - IS INCREASED HCV CASE-FINDING COMBINED WITH 8 OR 12 WEEK INTERFERON-FREE DIRECT-ACTING ANTIVIRAL TREATMENT COST EFFECTIVE IN UK PRISONS? A COST UTILITY ANALYSIS INCLUDING TREATMENT AS PREVENTION BENEFITS
 
 
  HCV Screening/treatment in UK Prisons Can be Cost-Effective, New Modeling Study by Natasha Martin: "Scaling-up treatment to PWID could substantially increase-cost-effectiveness due to prevention benefit"
 
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Natasha Martin, Associate Professor, UC San Diego
Prof Matthew Hickman & Prof Peter Vickerman, Univ of Bristol

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif